These endogenous vasoactive peptides inhibit the harmful cardiovascular reactions of ang II and aldosterone in patients with atherosclerosis and HF, such as endothelial dysfunction, sympathetic activation, vasoconstriction, hypertrophy and sodium retention18–21. The gene discussed is AGT; the disease is atherosclerosis.